Skip to content

To assess the effect of dexamethasone added to bupivacaine for postoperative analgesia by the Transverse Abdominis Plane (TAP) block.

To evaluate and compare the effects of different doses of dexamethasone added to bupivacaine on postoperative analgesia provided by the Transverse Abdominis Plane (TAP) block in patients undergoing lower abdominal surgeries. - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105223
Enrollment
90
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexamethasone 4mg: 4mg dexamethasone added in (0.25%) bupivacaine to make a total volume of 20mL given as 10 mL on each side for bilateral TAP block. Intervention2: Dexamethasone 8mg:

Sponsors

Pallavi Mutreja
Lead Sponsor
Dr Preeti Dahiya
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA I-II scheduled for elective lower abdominal surgeries

Exclusion criteria

Exclusion criteria: ASA III and above with coagulopathy diabetes known allergic to local anesthetics and infection at the surgical site

Design outcomes

Primary

MeasureTime frame
To compare the duration of postoperative analgesia among patients receiving TAP block with bupivacaine and varying doses of dexamethasoneTimepoint: Within 24 hrs

Secondary

MeasureTime frame
To assess quality and efficacy of analgesiaTimepoint: Over 24 hrs;To determine postoperative opioid consumptionTimepoint: 24 hrs;To monitor and assess blood sugar levels adverse effectTimepoint: Every 4 hourly till 12 hr and then at 24 th hour

Countries

India

Contacts

Public ContactPreeti Dahiya

World college of medical sciences and research hospital

barbia29@gmail.com8375933406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026